CEO Simon Michel provides an update on Ypsomed's (SIX: YPSN) first quarter of fiscal year 2026/27. Thanks to new customer projects spanning many therapeutic areas, international recognition for its innovation,...
Ypsomed has been honoured with the renowned Red Dot Award in the Product Design category for its new YpsoLoop autoinjector platform. YpsoLoop combines recyclability with user-friendliness in an innovative platform...
Ypsomed and ten23 health announced the next milestone in their strategic partnership for the YpsoDose wearable injector. By installing dedicated device assembly capabilities for Ypsomed's large-volume wearable injector, ten23 health is further...
This May, the international clinical research community gathered in Barcelona for the 16th Annual Outsourcing in Clinical Trials (OCT) Europe 2026 (6-7 May). As a premier forum for pharmaceutical leaders,...
At GeoStorage, quality is not merely a requirement; it is the foundation of everything we do. We are proud to announce the successful completion of our latest Good Distribution Practice (GDP) recertification...
Ypsomed opened its new tool manufacturing facility in Solothurn, thereby expanding its capacity to design and manufacture plastic injection moulds for pens and autoinjectors. In addition to its existing tool...
Ypsomed (SIX: YPSN) closed the financial year 2025/26 with consolidated revenue of CHF731.0m (prior year: CHF748.9m). Delivery Systems, the Company's core business segment, reported revenue of CHF601.5m for the period...
Ypsomed launches YpsoLoop, the first autoinjector platform designed for circularity. The two new 1ml and 2ml platform versions enable material recovery through a design enabling automated disassembly and efficient recycling,...
Visienco AG has won first prize at the Ypsomed Innovation Award 2026. The startup is developing an automated process for producing mini organs, known as organoids, which can be used...
Ypsomed (SIX: YPSN) is expanding its clinical excellence offering to support faster and more reliable clinical trials for subcutaneous injectable drugs. With CliniPilot and the Clear-to-Clinic approach, Ypsomed combines ready-to-use...
